Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

A study of enterocyte membranes during activation of apoptotic processes in chronic carrageenan-induced gastroenterocolitis.

Tkachenko A, Marakushyn D, Kalashnyk I, Korniyenko Y, Onishchenko A, Gorbach T, Nakonechna O, Posokhov Y, Tsygankov A.

Med Glas (Zenica). 2018 Aug 1;15(2):87-92. doi: 10.17392/946-18.

2.

Effect of carrageenans alone and in combination with casein or lipopolysaccharide on human epithelial intestinal HT-29 cells.

Sokolova EV, Kuz'mich AS, Byankina AO, Yermak IM.

J Biomed Mater Res A. 2017 Oct;105(10):2843-2850. doi: 10.1002/jbm.a.36136. Epub 2017 Jul 14.

PMID:
28589676
3.

Digestive fate of dietary carrageenan: Evidence of interference with digestive proteolysis and disruption of gut epithelial function.

Fahoum L, Moscovici A, David S, Shaoul R, Rozen G, Meyron-Holtz EG, Lesmes U.

Mol Nutr Food Res. 2017 Mar;61(3). doi: 10.1002/mnfr.201600545. Epub 2017 Jan 25.

PMID:
27718308
4.

Enhanced effect of κ-carrageenan on TNBS-induced inflammation in mice.

Wei W, Feng W, Xin G, Tingting N, Zhanghe Z, Haimin C, Xiaojun Y.

Int Immunopharmacol. 2016 Oct;39:218-228. doi: 10.1016/j.intimp.2016.07.031. Epub 2016 Aug 3.

PMID:
27494685
5.

Synergistic effect of κ-carrageenan on oxazolone-induced inflammation in BALB/c mice.

Wu W, Wang F, Gao X, Niu T, Zhu X, Yan X, Chen H.

BMC Gastroenterol. 2016 Mar 25;16:41. doi: 10.1186/s12876-016-0459-7.

6.

Synthesis and In Vitro Evaluation of Thiolated Carrageenan.

Suchaoin W, Bonengel S, Hussain S, Huck CW, Ma BN, Bernkop-Schnürch A.

J Pharm Sci. 2015 Aug;104(8):2523-30. doi: 10.1002/jps.24514. Epub 2015 Jun 2.

PMID:
26038249
7.

Oral bioavailability and pharmacodynamic activity of hesperetin nanocrystals generated using a novel bottom-up technology.

Shete G, Pawar YB, Thanki K, Jain S, Bansal AK.

Mol Pharm. 2015 Apr 6;12(4):1158-70. doi: 10.1021/mp5008647. Epub 2015 Mar 25.

PMID:
25785392
8.

Pro-apoptotic action of macrophage inhibitory cytokine 1 and counteraction of activating transcription factor 3 in carrageenan-exposed enterocytes.

Choi HJ, Kim HG, Kim J, Park SH, Park J, Oh CG, Do KH, Lee SJ, Park YC, Ahn SC, Kim YS, Moon Y.

Toxicol Lett. 2014 Nov 18;231(1):1-8. doi: 10.1016/j.toxlet.2014.08.022. Epub 2014 Aug 30.

PMID:
25180886
9.

Increased expression of colonic Wnt9A through Sp1-mediated transcriptional effects involving arylsulfatase B, chondroitin 4-sulfate, and galectin-3.

Bhattacharyya S, Feferman L, Tobacman JK.

J Biol Chem. 2014 Jun 20;289(25):17564-75. doi: 10.1074/jbc.M114.561589. Epub 2014 Apr 28.

10.

κ-carrageenan induces the disruption of intestinal epithelial Caco-2 monolayers by promoting the interaction between intestinal epithelial cells and immune cells.

Jiang HY, Wang F, Chen HM, Yan XJ.

Mol Med Rep. 2013 Dec;8(6):1635-42. doi: 10.3892/mmr.2013.1726. Epub 2013 Oct 14.

PMID:
24126493
11.

Mechanistic basis for unexpected bioavailability enhancement of polyelectrolyte complexes incorporating BCS class III drugs and carrageenans.

Heinen C, Reuss S, Saaler-Reinhardt S, Langguth P.

Eur J Pharm Biopharm. 2013 Sep;85(1):26-33. doi: 10.1016/j.ejpb.2013.03.010.

PMID:
23958316
12.

Bone marrow transplantation rescues intestinal mucosa after whole body radiation via paracrine mechanisms.

Chang YH, Lin LM, Lou CW, Chou CK, Ch'ang HJ.

Radiother Oncol. 2012 Dec;105(3):371-7. doi: 10.1016/j.radonc.2012.10.005. Epub 2012 Nov 9.

PMID:
23146318
13.

Pro-inflammatory NF-κB and early growth response gene 1 regulate epithelial barrier disruption by food additive carrageenan in human intestinal epithelial cells.

Choi HJ, Kim J, Park SH, Do KH, Yang H, Moon Y.

Toxicol Lett. 2012 Jun 20;211(3):289-95. doi: 10.1016/j.toxlet.2012.04.012. Epub 2012 Apr 26.

PMID:
22561171
14.

Exposure to common food additive carrageenan leads to reduced sulfatase activity and increase in sulfated glycosaminoglycans in human epithelial cells.

Yang B, Bhattacharyya S, Linhardt R, Tobacman J.

Biochimie. 2012 Jun;94(6):1309-16. doi: 10.1016/j.biochi.2012.02.031. Epub 2012 Mar 5.

15.

Molecular signature of kappa-carrageenan mimics chondroitin-4-sulfate and dermatan sulfate and enables interaction with arylsulfatase B.

Bhattacharyya S, Tobacman JK.

J Nutr Biochem. 2012 Sep;23(9):1058-63. doi: 10.1016/j.jnutbio.2011.05.012. Epub 2011 Nov 12.

PMID:
22079206
16.

Chemoprevention of DMH-induced rat colon carcinoma initiation by combination administration of piroxicam and C-phycocyanin.

Saini MK, Vaiphei K, Sanyal SN.

Mol Cell Biochem. 2012 Feb;361(1-2):217-28. doi: 10.1007/s11010-011-1106-9. Epub 2011 Oct 12.

PMID:
21989718
17.
18.

Construction of biosensor systems for determining the pathophysiological potential of carrageenan variants.

Riedel A, End C, Christiansen H, Renner M, Bender C, Schmidt S, Korn B, Sueltmann H, Mollenhauer J.

Mol Biosyst. 2009 Sep;5(9):973-9. doi: 10.1039/b901882b. Epub 2009 May 13.

PMID:
19668862
19.

DMBT1 functions as pattern-recognition molecule for poly-sulfated and poly-phosphorylated ligands.

End C, Bikker F, Renner M, Bergmann G, Lyer S, Blaich S, Hudler M, Helmke B, Gassler N, Autschbach F, Ligtenberg AJ, Benner A, Holmskov U, Schirmacher P, Nieuw Amerongen AV, Rosenstiel P, Sina C, Franke A, Hafner M, Kioschis P, Schreiber S, Poustka A, Mollenhauer J.

Eur J Immunol. 2009 Mar;39(3):833-42. doi: 10.1002/eji.200838689.

20.

Carrageenan induces cell cycle arrest in human intestinal epithelial cells in vitro.

Bhattacharyya S, Borthakur A, Dudeja PK, Tobacman JK.

J Nutr. 2008 Mar;138(3):469-75.

Supplemental Content

Loading ...
Support Center